Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rajkumar

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Cancer Genetics and Cytogenetics|August 25, 1999
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myelomaS V Rajkumar, R Fonseca, G W Dewald, et al.
Leukemia|August 10, 2011
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphomaV Ramakrishnan, S Ansell, J Haug, et al.
Leukemia|June 29, 2020
N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progressionAngela Dispenzieri, D R Larson, S V Rajkumar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Oncogene|November 26, 2009
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugsV Ramakrishnan, M Timm, J L Haug, et al.
Mayo Clinic Proceedings|September 20, 2000
Thalidomide in the treatment of relapsed multiple myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Bone Marrow Transplantation|March 12, 2008
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCTS K Kumar, D Dingli, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapyB Siontis, S Kumar, A Dispenzieri, et al.
Leukemia|March 22, 2013
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaS V Rajkumar, V Gupta, R Fonseca, et al.
Journal of Fish Diseases|January 29, 2024
Development and characterization of brain cell line from Trachinotus blochii and its application in virological and gene expression studiesA Nafeez Ahmed, S Mithra, S Suryakodi, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Cancer Genetics and Cytogenetics|August 25, 1999
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myelomaS V Rajkumar, R Fonseca, G W Dewald, et al.
Leukemia|August 10, 2011
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphomaV Ramakrishnan, S Ansell, J Haug, et al.
Leukemia|June 29, 2020
N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progressionAngela Dispenzieri, D R Larson, S V Rajkumar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Oncogene|November 26, 2009
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugsV Ramakrishnan, M Timm, J L Haug, et al.
Mayo Clinic Proceedings|September 20, 2000
Thalidomide in the treatment of relapsed multiple myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Bone Marrow Transplantation|March 12, 2008
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCTS K Kumar, D Dingli, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapyB Siontis, S Kumar, A Dispenzieri, et al.
Leukemia|March 22, 2013
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaS V Rajkumar, V Gupta, R Fonseca, et al.
Journal of Fish Diseases|January 29, 2024
Development and characterization of brain cell line from Trachinotus blochii and its application in virological and gene expression studiesA Nafeez Ahmed, S Mithra, S Suryakodi, et al.
Pageof 17